Campbell & Co Investment Adviser’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $634K | Sell |
9,184
-35,785
| -80% | -$2.47M | 0.04% | 703 |
|
|
2025
Q1 | $3.12M | Buy |
44,969
+39,923
| +791% | +$2.77M | 0.24% | 90 |
|
|
2024
Q4 | $434K | Sell |
5,046
-5,632
| -53% | -$484K | 0.03% | 707 |
|
|
2024
Q3 | $1.27M | Sell |
10,678
-5,726
| -35% | -$682K | 0.09% | 347 |
|
|
2024
Q2 | $2.34M | Sell |
16,404
-14
| -0.1% | -$2K | 0.2% | 126 |
|
|
2024
Q1 | $2.11M | Buy |
+16,418
| New | +$2.11M | 0.18% | 131 |
|
|
2023
Q4 | – | Sell |
-5,219
| Closed | -$475K | – | 1275 |
|
|
2023
Q3 | $475K | Sell |
5,219
-7,945
| -60% | -$723K | 0.06% | 537 |
|
|
2023
Q2 | $1.07M | Sell |
13,164
-7,574
| -37% | -$613K | 0.19% | 130 |
|
|
2023
Q1 | $1.65M | Buy |
+20,738
| New | +$1.65M | 0.31% | 44 |
|
|
2022
Q4 | – | Sell |
-6,704
| Closed | -$334K | – | 928 |
|
|
2022
Q3 | $334K | Sell |
6,704
-866
| -11% | -$43.1K | 0.08% | 445 |
|
|
2022
Q2 | $422K | Buy |
+7,570
| New | +$422K | 0.11% | 331 |
|
|
2021
Q1 | – | Sell |
-5,734
| Closed | -$200K | – | 558 |
|
|
2020
Q4 | $200K | Buy |
+5,734
| New | +$200K | 0.12% | 366 |
|
|
2019
Q2 | – | Sell |
-9,724
| Closed | -$254K | – | 652 |
|
|
2019
Q1 | $254K | Buy |
9,724
+734
| +8% | +$19.2K | 0.12% | 342 |
|
|
2018
Q4 | $229K | Sell |
8,990
-5,822
| -39% | -$148K | 0.23% | 253 |
|
|
2018
Q3 | $349K | Buy |
+14,812
| New | +$349K | 0.24% | 160 |
|
|
2013
Q3 | – | Sell |
-37,960
| Closed | -$588K | – | 332 |
|
|
2013
Q2 | $588K | Buy |
+37,960
| New | +$588K | 0.11% | 197 |
|